Skip to main content
Top
Published in: Clinical & Experimental Metastasis 5/2007

Open Access 01-09-2007 | Research Paper

An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis

Authors: Maroesja J. van Nimwegen, Saertje Verkoeijen, Peter J. K. Kuppen, Jurjen H. L. Velthuis, Bob van de Water

Published in: Clinical & Experimental Metastasis | Issue 5/2007

Login to get access

Abstract

To study the tumor cell autonomous processes of metastasis, an in vivo tumor metastasis model is required that excludes the involvement of the innate immune system. For this purpose we used the established syngeneic MTLn3 cell – Fischer 344 tumor model. MTLn3 cells are efficiently eradicated by NK cells in vivo. Using isolated cell systems, we provide evidence for apoptosis-induction by IL-2 activated NK cells, but not T-cells, despite the expression of MHC class I. This is largely mediated by the perforin/granzyme B pathway in MTLn3 cells in a caspase-dependent manner. Temporal in vivo depletion of NK cells by an antibody-based method, dramatically improved colonization of the lungs by MTLn3 cells, from 5 metastases in the untreated animals to 130 metastases in the NK-depleted animals. Thus, we improved the syngeneic MTLn3-Fischer 344 tumor model by temporal depletion of NK cells of which the advantages over the use of immunodeficient animals are evident.
Literature
3.
go back to reference Neri A, Welch D, Kawaguchi T et al (1982) Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 68:507–517PubMed Neri A, Welch D, Kawaguchi T et al (1982) Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 68:507–517PubMed
4.
go back to reference Welch DR, Neri A, Nicolson GL (1983) Comparison of ‘spontaneous’ and ‘‘experimental’ metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis 3:65–80PubMed Welch DR, Neri A, Nicolson GL (1983) Comparison of ‘spontaneous’ and ‘‘experimental’ metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis 3:65–80PubMed
5.
go back to reference Bouzahzah B, Albanese C, Ahmed F et al (2001) Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 7:816–830PubMed Bouzahzah B, Albanese C, Ahmed F et al (2001) Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 7:816–830PubMed
6.
go back to reference Melamed R, Rosenne E, Shakhar K et al (2005) Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19:114–126PubMedCrossRef Melamed R, Rosenne E, Shakhar K et al (2005) Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19:114–126PubMedCrossRef
7.
go back to reference Ben Eliyahu S, Page GG, Yirmiya R et al (1996) Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med 2:457–460PubMedCrossRef Ben Eliyahu S, Page GG, Yirmiya R et al (1996) Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med 2:457–460PubMedCrossRef
8.
go back to reference Ben Eliyahu S, Page GG, Yirmiya R et al (1999) Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80:880–888PubMedCrossRef Ben Eliyahu S, Page GG, Yirmiya R et al (1999) Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80:880–888PubMedCrossRef
9.
go back to reference Barlozzari T, Leonhardt J, Wiltrout RH et al (1985) Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 134:2783–2789PubMed Barlozzari T, Leonhardt J, Wiltrout RH et al (1985) Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 134:2783–2789PubMed
10.
go back to reference Huigsloot M, Tijdens IB, Mulder GJ et al (2002) Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 277:35869–35879PubMedCrossRef Huigsloot M, Tijdens IB, Mulder GJ et al (2002) Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 277:35869–35879PubMedCrossRef
11.
go back to reference Huigsloot M, Tijdens RB, van de Water B (2003) Inhibition of protein kinase Calpha enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2. Mol Pharmacol 64:965–973PubMedCrossRef Huigsloot M, Tijdens RB, van de Water B (2003) Inhibition of protein kinase Calpha enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2. Mol Pharmacol 64:965–973PubMedCrossRef
12.
go back to reference van Nimwegen MJ, Huigsloot M, Camier A et al (2006) Focal adhesion kinase (FAK) and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol Pharmacol 70: van Nimwegen MJ, Huigsloot M, Camier A et al (2006) Focal adhesion kinase (FAK) and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol Pharmacol 70:
13.
go back to reference van Nimwegen MJ, Verkoeijen S, van Buren L et al (2005) Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res 65:4698–4706PubMedCrossRef van Nimwegen MJ, Verkoeijen S, van Buren L et al (2005) Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res 65:4698–4706PubMedCrossRef
14.
go back to reference Velthuis JH, de Bont HJ, Medema JP et al (2003) Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells. Immunobiology 207:115–127PubMedCrossRef Velthuis JH, de Bont HJ, Medema JP et al (2003) Interleukin-2 activated NK cells do not use the CD95L- and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells. Immunobiology 207:115–127PubMedCrossRef
15.
go back to reference Fukumoto T, McMaster WR, Williams AF (1982) Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol 12:237–243PubMedCrossRef Fukumoto T, McMaster WR, Williams AF (1982) Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol 12:237–243PubMedCrossRef
16.
go back to reference Huigsloot M, Tijdens IB, Mulder GJ et al (2001) Differential regulation of phosphatidylserine externalization and DNA fragmentation by caspases in anticancer drug-induced apoptosis of rat mammary adenocarcinoma MTLn3 cells. Biochem Pharmacol 62:1087–1097PubMedCrossRef Huigsloot M, Tijdens IB, Mulder GJ et al (2001) Differential regulation of phosphatidylserine externalization and DNA fragmentation by caspases in anticancer drug-induced apoptosis of rat mammary adenocarcinoma MTLn3 cells. Biochem Pharmacol 62:1087–1097PubMedCrossRef
17.
go back to reference van den Brink MR, Hunt LE, Hiserodt JC (1990) In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 171:197–210PubMedCrossRef van den Brink MR, Hunt LE, Hiserodt JC (1990) In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 171:197–210PubMedCrossRef
18.
go back to reference Velthuis JH, Stitzinger M, Aalbers RI et al (2003) Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis. Clin Exp Metastasis 20:713–721PubMedCrossRef Velthuis JH, Stitzinger M, Aalbers RI et al (2003) Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis. Clin Exp Metastasis 20:713–721PubMedCrossRef
19.
go back to reference Nausch N, Florin L, Hartenstein B et al (2006) Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon. J Immunol 176:7–11PubMed Nausch N, Florin L, Hartenstein B et al (2006) Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon. J Immunol 176:7–11PubMed
20.
go back to reference Savithri B, Khar A (2006) A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D. Eur J Immunol 36:107–117PubMedCrossRef Savithri B, Khar A (2006) A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D. Eur J Immunol 36:107–117PubMedCrossRef
21.
go back to reference Smyth MJ, Swann J, Cretney E et al (2005) NKG2D function protects the host from tumor initiation. J Exp Med 202:583–588PubMedCrossRef Smyth MJ, Swann J, Cretney E et al (2005) NKG2D function protects the host from tumor initiation. J Exp Med 202:583–588PubMedCrossRef
22.
go back to reference Le Maux CB, Moretta A, Vergnon I et al (2005) NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J Immunol 175:5790–5798 Le Maux CB, Moretta A, Vergnon I et al (2005) NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J Immunol 175:5790–5798
23.
go back to reference Velthuis JH, Rouschop KM, de Bont HJ et al (2002) Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis. J Biol Chem 277:24,631–24,637CrossRef Velthuis JH, Rouschop KM, de Bont HJ et al (2002) Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis. J Biol Chem 277:24,631–24,637CrossRef
24.
go back to reference Welch DR, Aeed PA, Earhart RH et al (1994) Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones. Anticancer Res 14:1743–1751PubMed Welch DR, Aeed PA, Earhart RH et al (1994) Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones. Anticancer Res 14:1743–1751PubMed
Metadata
Title
An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis
Authors
Maroesja J. van Nimwegen
Saertje Verkoeijen
Peter J. K. Kuppen
Jurjen H. L. Velthuis
Bob van de Water
Publication date
01-09-2007
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 5/2007
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-007-9075-9

Other articles of this Issue 5/2007

Clinical & Experimental Metastasis 5/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine